Skip to main content
SpringerLink
Log in

Early Renal Hyperfunction and Hypertrophy in IDDM Patients Including Comments on Early Intervention

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

  • 109 Accesses

Abstract

Diabetic nephropathy is the main cause of reduced survival in insulin-dependent diabetes. Much interest is paid to early alterations in kidney function and structure, since a relationship may exist between such early abnormalities and later development of diabetic nephropathy. A modest increase in urinary albumin excretion, microalbuminuria, has been identified as an early marker of diabetic nephropathy, and therapeutical intervention postponing the onset of overt nephropathy has been introduced. In this chapter the initial renal changes in IDDM, glomerular hyperfunction and renal hypertrophy, will be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mogensen CE. Glomerular hyperfiltration in human diabetes. Diabetes Care 1994; 17: 770–775.

    CAS  PubMed  Google Scholar 

  2. Bank N. Mechanisms of diabetic hyperfiltration. Nephrology Forum. Kidney Int 1991; 40: 792–807.

    CAS  Google Scholar 

  3. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971; 28: 91–100.

    Article  CAS  PubMed  Google Scholar 

  4. Ditzel J, Schwartz M. Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 1976; 16: 264–267.

    Google Scholar 

  5. Christensen JS, Gammelgaard J, Frandsen M, Parving H-H. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 1981; 20: 451–456.

    Google Scholar 

  6. Brøchner-Mortensen J, Ditzel J. Glomerular filtration rate and extracellular fluid volume in insulin-dependent patients with diabetes mellitus. Kidney Int 1982; 21: 696–698.

    Article  PubMed  Google Scholar 

  7. Hansen KW, Mau Pedersen M, Christensen CK, Schmitz A, Christiansen JS, Mogensen CE. Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients. J Intern Med 1992; 232: 161–167.

    Article  CAS  PubMed  Google Scholar 

  8. Mogensen CE. Kidney function and glomerular permeability to macromolecules in juvenile diabetes. Dan Med Bull 1972; 19: 1–36.

    PubMed  Google Scholar 

  9. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving H-H. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683–688.

    Article  CAS  PubMed  Google Scholar 

  10. Nyberg G, Granerus G, Aurell M. Renal extraction ratios for 51Cr-EDTA, PAH, and glucose in early insulin-dependent diabetic patients. Kidney Int 1982; 21: 706–708.

    Article  CAS  PubMed  Google Scholar 

  11. Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 1985; 2: 97–102.

    Article  CAS  PubMed  Google Scholar 

  12. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.

    Article  CAS  PubMed  Google Scholar 

  13. Ellis EN, Steffes MW, Coetz FC, Sutherland DER, Mauer SM. Glomerular filtration surface in type 1 diabetes mellitus. Kidney Int 1986; 29: 889–894.

    Article  CAS  PubMed  Google Scholar 

  14. Christiansen JS, Frandsen M, Parving H-H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981; 20: 199–204.

    CAS  PubMed  Google Scholar 

  15. Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22: 706–713.

    CAS  PubMed  Google Scholar 

  16. Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment. Diabetologia 1975; 11: 221–224.

    Article  CAS  PubMed  Google Scholar 

  17. Puig JG, Antón FM, Grande C, Pallardo LF, Arnalich F, Gil A, Vazquez JJ, Garcia AM. Relation on kidney size to kidney function in early insulin-dependent diabetes. Diabetologia 1981; 21: 363–367.

    Article  Google Scholar 

  18. Schwieger J, Fine LG. Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus. Semin Nephrol 1990; 10: 242–253.

    CAS  PubMed  Google Scholar 

  19. Feldt-Rasmussen B, Hegedüs L, Mathiesen ER, Deckert T. Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control. Scand J Lab Invest 1991; 51: 31–36.

    CAS  Google Scholar 

  20. Østerby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus: I. Early abnormalities. Diabetologia 1975; 11: 225–229.

    Article  PubMed  Google Scholar 

  21. Seyer-Hansen K, Hansen J, Gundersen HJG. Renal hypertrophy in experimental diabetes: a morphometric study. Diabetologia 1980; 18: 501–505.

    Article  CAS  PubMed  Google Scholar 

  22. Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving H-H. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985; 34: 1301–1305.

    Article  CAS  PubMed  Google Scholar 

  23. Wolpert HA, Kinsley BT, Clermont AC, Wald H, Bursell S-E. Hyperglycaemia modulates retinal hemodynamics in IDDM. Diabetes 1993; 42: A489.

    Google Scholar 

  24. Gray SD. Effect of hypertonicity on vascular dimensions in skeletal muscle. Microvasc Res 1971; 3: 117–124.

    Article  CAS  PubMed  Google Scholar 

  25. Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991; 40: 792–807.

    Article  CAS  PubMed  Google Scholar 

  26. Harvey JN, Edmundson AW, Jaffa AA, Martin LL, Mayfield RK. Renal excretion of kallikrein and eicosanoids in patients with Type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia 1992; 35: 857–862.

    Article  CAS  PubMed  Google Scholar 

  27. Perico N, Benigni A, Gabanelli M, Piccinelli A, Rog M, De-Riva C, Remuzzi G. Atrial natriuretide peptide and prostacyclin synergistically mediate hyperfiltration and hypoperfusion of diabetic rats. Diabetes 1992; 41: 533–538.

    Article  CAS  PubMed  Google Scholar 

  28. Blantz RC, Peterson OW, Gushwa L, Tucker BJ. Effect of modest hyperglycaemia on tubuloglo-merular feedback activity. Kidney Int 1982; 22: S206–S212.

    Google Scholar 

  29. Christiansen JS, Christensen CK, Hermansen K, Pedersen EB, Mogensen CE. Enhancement of glomerular filtration rate and renal plasma flow by oral glucose load in well controlled insulin-dependent diabetics. Scand J Clin Lab Invest 1986; 46: 265–272.

    Article  Google Scholar 

  30. Christiansen JS, Frandsen M, Parving H-H. Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia 1981; 21: 368–373.

    Article  CAS  PubMed  Google Scholar 

  31. Wiseman MJ, Mangili R, Alberetto M, Keen H, Viberti GC. Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int 1987; 31: 1012–1018.

    Article  CAS  PubMed  Google Scholar 

  32. Mogensen CE. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest 1971; 28: 177–182.

    Article  CAS  PubMed  Google Scholar 

  33. Marre M, Dubin T, Hallab M, Berrut G, Bouhanick B, Lejeune J-J, Fressinaud P. Different renal response to hyperglycaemia in insulin-dependent diabetics at risk for, or protected against diabetic nephropathy. Diabetes 1993; 42: A423.

    Google Scholar 

  34. Skøtt P, Vaag A, Hother-Nielsen O, Andersen P, Bruun NE, Giese J, Beck-Nielsen H, Parving H-H. Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 715–727.

    Article  PubMed  Google Scholar 

  35. Mathiesen ER, Gall M-A, Hommel E, Skøtt P, Parving H-H. Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Diabetic Med 1989; 6: 595–600.

    Article  CAS  PubMed  Google Scholar 

  36. Christensen CK, Christiansen JS, Schmitz A, Christensen T, Hermansen K, Mogensen CE. Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients — a two years controlled study. J Diabetes and Its Complications 1987; 1: 91–95.

    Article  CAS  Google Scholar 

  37. Mogensen CE, Christensen CK, Mau Pedersen M, Alberti KGMM, Boye N, Christensen T, Christiansen JS, Flyvbjerg A, Ingerslev J, Schmitz A, Ørskov H. Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. J Diabetic Compl 1990; 4: 159–165.

    Article  CAS  Google Scholar 

  38. Mau Pedersen M, Christiansen JS, Pedersen EB, Mogensen CE. Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycémie control. Clin Sci 1992; 83: 445–451.

    Google Scholar 

  39. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599–606.

    Article  CAS  PubMed  Google Scholar 

  40. Mau Pedersen M, Christiansen JS, Mogensen CE. Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition. Diabetes 1991; 40: 527–531.

    Article  Google Scholar 

  41. Mau Pedersen M, Mogensen CE, Christiansen JS. Reduction of glomerular hyperfiinction during short-term aldose reductase inhibition in normoalbuminuric, insulin-dependent diabetic patients. Endocrinol Metab 1995; 2: 55–62.

    Google Scholar 

  42. Passariello N, Sepe J, Marrazzo G, De Cicco A, Peluso A, Pisano MCA, Sgambato S, Tesauro P, D’Onofrio F. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate in IDDM subjects with nephropathy. Diabetes Care 1993; 16: 789–795.

    Article  CAS  PubMed  Google Scholar 

  43. Trevisan R, Nosadini R, Fioretto P, Avogaro A, Duner E, Iori E, Valerio A, Doria A, Crepaldi G. Ketone bodies increase glomerular filtration rate in normal man and in patients with type 1 (insulin dependent) diabetes. Diabetologia 1987; 30: 214–221.

    Article  CAS  PubMed  Google Scholar 

  44. Gwinup G, Elias AN. Hypothesis. Insulin is responsible for the vascular complications of diabetes. Med Hypotheses 1991; 34: 1–6.

    Article  CAS  PubMed  Google Scholar 

  45. Christiansen JS, Frandsen M, Parving H-H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981; 20: 199–204.

    CAS  PubMed  Google Scholar 

  46. Skøtt P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck-Nielsen H, Parving H-H. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989; 32: 694–699.

    Article  PubMed  Google Scholar 

  47. Ortola FY, Ballermann BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest 1987; 80: 670–674.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Kikkawa R, Haneda M, Sakamoto K, Koya D, Shikano T, Nakanishi S, Matsuda Y, Shigeta Y. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats. Biochem Biophys Res Commun 1993; 193: 700–705.

    Article  CAS  PubMed  Google Scholar 

  49. Christiansen JS, Gammelgaard J, Frandsen M, Orskov H, Parving H-H. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 1981; 11: 487–490.

    Article  CAS  PubMed  Google Scholar 

  50. Parving H-H, Christiansen JS, Noer I, Tronier B, Mogensen CE. The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics. Diabetologia 1980; 19: 350–354.

    Article  CAS  PubMed  Google Scholar 

  51. Hoogenberg K, Dullaart RPF, Freling NJM, Meijer S, Sluiter WJ. Contributory roles of circulatory glucagon and growth hormone to increased renal haemodynamics in type 1 (insulin-dependent) diabetes mellitus. Scand J Clin Lab Invest 1993; 53: 821–828.

    Article  CAS  PubMed  Google Scholar 

  52. Flyvbjerg A. »The role of insulin-like growth factor I in initial renal hypertrophy in experimental diabetes.« In Growth Hormone and Insulin-Like Growth Factor I. Flyvbjerg A, Ørskov H, Alberti KGMM, eds. John Wiley & Sons Ltd., 1993; pp 271-306.

    Google Scholar 

  53. Castellino P, Hunt W, DeFronzo RA. Regulation of renal hemodynamics by plasma amino acid and hormone concentrations. Kidney Int 1987; 32: S–15–S–20.

    Google Scholar 

  54. Mau Pedersen M, Mogensen CE, Schönau Jørgensen F, Møller B, Lykke G, Pedersen O. Renal effects from limitation of high dietary protein in normoalbuminuric diabetic patients. Kidney Int 1989; 36: S–115–S–121.

    Google Scholar 

  55. Mau Pedersen M, Winther E, Mogensen CE. Reducing protein in the diabetic diet. Diabete Metab (Paris) 1990; 16: 454–459.

    Google Scholar 

  56. Jones MG, Lee K, Swaminathan R. The effect of dietary protein on glomerular filtration rate in normal subjects. Clin Nephrol 1987; 27: 71–75.

    CAS  PubMed  Google Scholar 

  57. Pecis M, de Azevedo MJ, Gross JL. Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care 1994; 17: 665–672.

    Article  CAS  PubMed  Google Scholar 

  58. Kraus ES, Cheng L, Sikorski I, Spector DA. Effects of phosphorus restriction on renal response to oral and intravenous protein loads in rats. Am J Physiol 1993; 264: F752–F759.

    CAS  PubMed  Google Scholar 

  59. Turtle KR, Bruto JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 1626–1632.

    Article  Google Scholar 

  60. Wisemann MJ, Saunders AJ, Keen H, Viberti GC. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312: 617–621.

    Article  Google Scholar 

  61. Shechter P, Boner G, Rabkin R. Tubular cell protein degradation in early diabetic renal hypertrophy. J Am Soc Nephrol 1994; 4: 1582–1587.

    CAS  PubMed  Google Scholar 

  62. Schaefer L, Schaefer RM, Ling, Teschner M, Heidland A. Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 1994; 37: 567–571.

    Article  CAS  PubMed  Google Scholar 

  63. Shankland SJ, Scholey JW, Ly H, Thai K. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 1994; 46: 430–442.

    Article  CAS  PubMed  Google Scholar 

  64. Wang YX, Brooks DP. The role of adenosine in glycine-induced glomerular hyperfiltration in rats. J Pharmacol Exp Ther 1992; 263: 1188–1194.

    CAS  PubMed  Google Scholar 

  65. Angielski S, Redlak M, Szczepanska KM. Intrarenal adenosine prevents hyperfiltration induced by atrial natriuretic factor. Miner Electrolyte Metab 1990; 16: 57–60.

    CAS  PubMed  Google Scholar 

  66. Wang YX, Gellai M, Brooks DP. Dopamine DAI receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats. Am J Physiol 1992; 262: F1055–F1060.

    CAS  PubMed  Google Scholar 

  67. Jaffa AA, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF, Mayfield RK. Evidence for renal kinins as mediators of amino acid-induced hyperfusion and hyperfiltration in the rat. J Clin Invest 1992; 89: 1460–1468.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Friedlander G, Blanchet BF, Nitenberg A, Laborie C, Assan R, Amiel C. Glucagon secretion is essential for aminoacid-induced hyperfiltration in man. Nephrol Dial Transplant 1990; 5: 110–117.

    Article  CAS  PubMed  Google Scholar 

  69. Wahren J, Johansson B-L, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia 1994; 37: Suppl. 2: S99–S107.

    Article  CAS  PubMed  Google Scholar 

  70. Bouhanick B, Suraniti S, Berrut G, Bled F, Simard G, Lejeune JJ, Fressinaud P, Marre M. Relationship between fat intake and glomerular filtration rate in normotensive insulin-dependent diabetic patients. Diabete Metab (Paris) 1995; 21: 168–172.

    CAS  Google Scholar 

  71. Hostetter TH. Diabetic nephropathy. Metabolic versus hemodynamic considerations. Diabetes Care 1992; 15: 1205–1215.

    Article  CAS  PubMed  Google Scholar 

  72. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986; 46: 201–206.

    Article  CAS  PubMed  Google Scholar 

  73. Rudberg S, Persson B, Dalqvist G. Increased glomerular filtration rate predicts diabetic nephropathy-results form an 8 year prospective study. Kidney Int 1992; 41: 822–828.

    Article  CAS  PubMed  Google Scholar 

  74. Chirelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 1995; 9: 154–158.

    Article  Google Scholar 

  75. Lervang H-H, Jensen S, Brøchner-Mortensen J, Ditzel J. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy? Diabetic Med 1992; 9: 635–640.

    Article  CAS  PubMed  Google Scholar 

  76. Jones SL, Wiseman MJ, Viberti GC. Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia 1991; 34: 59–60.

    Article  CAS  PubMed  Google Scholar 

  77. Anderson S. Renal effects of converting enzyme inhibitors in hypertension and diabetes. J Cardiovasc Pharmacol 1990; 15: Suppl. 3: S11–S15.

    Article  PubMed  Google Scholar 

  78. Mau Pedersen M, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. Clin Invest Med 1991; 14: 642–651.

    Google Scholar 

  79. Bakris GL, Slataper R, Vicknair N, Sadler R. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetic Compl 1994; 8: 2–6.

    Article  CAS  Google Scholar 

  80. Mau Pedersen M, Christensen SE, Christiansen JS, Pedersen EB, Mogensen CE, Ørskov H. Acute effects of a somatostatin analogue on kidney function in type i diabetic patients. Diabetic Med 1990; 7: 304–309.

    Article  Google Scholar 

  81. Serri O, Beauregard H, Brazeau P, Abribat T, Lamber J, Harris A, Vachon L. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265; 888–892.

    Article  CAS  PubMed  Google Scholar 

  82. Mau Pedersen M, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabetic Med 1988; 5: 562–569.

    Article  Google Scholar 

  83. Chiarelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 1995; 9: 154–158.

    Article  CAS  PubMed  Google Scholar 

  84. Ichikawa I, Harris RC. Angiotensin actions in the kidney: Renewed insight into the old hormone (Editorial Review). Kidney Int 1991; 40: 583–596.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department M, Aarhus Kommunehospital, Aarhus, Denmark

    Margrethe Mau Pedersen

Authors
  1. Margrethe Mau Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital University Hospitals in Aarhus, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pedersen, M.M. (1996). Early Renal Hyperfunction and Hypertrophy in IDDM Patients Including Comments on Early Intervention. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6749-0_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6749-0_34

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6751-3

  • Online ISBN: 978-1-4757-6749-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation